COVID-19 and Harm Reduction Programme Implementation: Sharing Experiences in Practice (Webinar)

Médecins du Monde Harm Reduction, April 2020

The COVID-19 pandemic is having a profound effect on the provision of health services across the globe and is further magnifying the existing barriers faced by people who use drugs in accessing harm reduction services. Programmes have had to adapt, and efforts are being made to enhance accessibility and ensure the continuity of harm reduction services in a context that is changing daily.

But what does this look like in reality, and what practical measures can be put in place to ensure that people who use drugs continue to have access to the services and support that they need?

The aim of this webinar is to facilitate an interactive discussion and share experiences on how to maintain and adapt harm reduction services during the COVID-19 pandemic.

Speakers will discuss:

• The impact of COVID-19 on the lives of people who use drugs and their use of services

• Community mobilisation and advocacy by people who use drugs

• Examples of how harm reduction programmes such as OST and NSP are continued in some countries

Organisers: Médecins du Monde, International Network of People Who Use Drugs, Harm Reduction International, European Network of People Who Use Drugs, the United Nations Office on Drugs and Crime and the World Health Organization.

Sexual and reproductive health a COVID-19 priority (Statement)

Burnet Institute, 28 May, 2020

Burnet Institute is a member of a consortium of Australian-based non-governmental organisations (NGOs) and academic institutes concerned about the detrimental effects of the COVID-19 pandemic on the sexual and reproductive health and rights of women and girls globally.

The International Sexual and Reproductive Health and Rights Consortium, which includes Save the Children, Family Planning NSW, CARE Australia, The Nossal Institute for Global Health, and Médecins Sans Frontières Australia, is calling on the Australian Government to prioritise the needs of women and girls in its response to COVID-19.

Collectively, the consortium works across 160 countries to champion universal access to sexual and reproductive health and rights.

It’s concerned that women and girls across the globe are struggling to access critical sexual and reproductive health care, citing evidence that COVID-19 lockdowns are likely to cause millions of unplanned pregnancies.

In the Pacific, travel to rural and remote areas have been curtailed, and physical distancing requirements have forced the cancellation of most group training on sexual and reproductive rights.

A recent UNFPA report determined that a six-month lockdown could mean 47 million women and girls globally cannot access contraception, and seven million will become pregnant.

The consortium has issued a joint statement setting out priorities to ensure Australia’s global response to COVID-19 meets the critical needs of all women and girls, including:

  • Recognise and respond to the gendered impacts of the pandemic, and the increased risk to women and girls from gender-based violence and other harmful practices
  • Improve the supply of contraceptives and menstrual health products which are being impacted by the strain and disruption on global supply chains
  • Increase flexibility in delivering sexual and reproductive health services during lockdown using innovative health delivery models such as task-sharing, tele-health and pharmacy distribution
  • Support sexual and reproductive health workers and clinics to continue delivering services sagely with access to personal protective equipment as well as training on how to refer, test or diagnose COVID-19.

 

SEXUAL HEALTH MATTERS: new clinical podcast from SHINE SA

SHINE SA, May 2020

Filled with quality clinical guidance and tips for best practice, SHINE SA’s new Sexual Health Matters – Clinical Podcast delves into the intimate regions of the body and broaches the uncomfortable conversations necessary to ensure client safety and sexual/reproductive well-being.

Through discussion, interview and explanation, experienced sexual health clinicians raise awareness of guidelines, resources, research and emerging trends to ensure that clinicians everywhere can provide excellent sexual and reproductive care to improve client outcomes.

If you have a topic you would like us to cover in future podcasts, email courses@shinesa.org.au to let us know!

New ‘Syphilis Is Still Out There’ Campaign for Health Professionals

The Aboriginal Health Council of South Australia (AHCSA) & SHINE SA, May 2020

The Aboriginal Health Council of South Australia (AHCSA) and SHINE SA have released a new social media campaign for health professionals.

The campaign aims to raise awareness of syphilis screening and treatment during COVID-19.

  • Syphilis Is Still Out There Campaign for Health Professionals

While we deal with the COVID-19 pandemic, the syphilis outbreak in South Australia continues. It’s essential that we continue to test, treat, cure and notify partners during this time.

To learn more visit www.shinesa.org.au/syphilisoutbreak

  • Social Media Tiles and Posters

To help support this campaign and reinforce key messages around syphilis prevention and treatment, we have a range of social media tiles and posters to download.

Help us share this campaign by downloading our social media tiles to share on Facebook, Instagram, Twitter and LinkedIn. Use the hashtag #SyphilisIsStillOutThere

Download the files here as a zipped folder: Syphilis Is Still Out There Campaign

Key Messages of this Campaign 

  • Syphilis is still out there #SyphilisIsStillOutThere
  • Syphilis outbreak minimised in 4 steps: test, treat, cure and notify partners
  • Syphilis is still threatening unborn children. Know when to test before, during and after pregnancy

  • For the Community

Stay tuned: whilst this campaign is aimed at health professionals, AHCSA are currently producing resources to share on social media targeted towards community members.

To stay up-to-date follow AHCSA on Facebook.

 

Keeping up with hepatitis, liver, and COVID-19 resources

Hepatitis SA, May 2020

Hepatitis SA currently have a collection of hepatitis/liver related COVID-19 resources available online through their library catalogue.

Hepatitis SA maintains a specialist library of physical and online resources; including books, reports, audio-visual resources, journals and newsletters, with the services of a professional librarian.

 

 

Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease

Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019. JAMA Network Open. 2020;3(5):e208292. doi:10.1001/jamanetworkopen.2020.8292

Research Letter

Infectious Diseases

May 7, 2020

Discussion

In this cohort study, we found that SARS-CoV-2 can be present in the semen of patients with COVID-19, and SARS-CoV-2 may still be detected in the semen of recovering patients. Owing to the imperfect blood-testes/deferens/epididymis barriers, SARS-CoV-2 might be seeded to the male reproductive tract, especially in the presence of systemic local inflammation. Even if the virus cannot replicate in the male reproductive system, it may persist, possibly resulting from the privileged immunity of testes. So far, researchers have found 27 viruses associated with viremia in human semen. But the presence of viruses in semen may be more common than currently understood, and traditional non–sexually transmitted viruses should not be assumed to be totally absent in genital secretions.5,6 Studies on viral detection and semen persistence are beneficial to clinical practice and public health, especially concerning viruses that could cause high mortality or morbidity, such as SARS-CoV-2.

This study is limited by the small sample size and the short subsequent follow-up. Therefore, further studies are required with respect to the detailed information about virus shedding, survival time, and concentration in semen.

If it could be proved that SARS-CoV-2 can be transmitted sexually in future studies, sexual transmission might be a critical part of the prevention of transmission, especially considering the fact that SARS-CoV-2 was detected in the semen of recovering patients.